Equity

3 Months Ended

Mar. 31, 2022

Stockholders Equity Note [Abstract]

Equity

Note 17. Equity

2018 Share Repurchase Program

In 2018, the Company’s board of directors approved a share repurchase program authorizing the purchase of shares of Chemours’ issued and outstanding common stock in an aggregate amount not to exceed $750, plus any associated fees or costs in connection with the Company’s share repurchase activity (the “2018 Share Repurchase Program”). In February 2019, the Company’s board of directors increased the authorization amount to $1,000. Under the 2018 Share Repurchase Program, shares of Chemours’ common stock can be purchased in the open market from time to time, subject to management’s discretion, as well as general business and market conditions.

The following table sets forth the Company’s share repurchase activity under the program for the three months ended March 31, 2022 and 2021.

	Three Months Ended March 31,
	2022		2021
Total number of shares purchased		4,851,966		—
Total amount for shares purchased	$	146	$	—
Average price paid per share	$	30.06	$	—

Through March 31, 2022, the Company purchased a cumulative 25,631,711 shares of Chemours’ issued and outstanding common stock, which amounted to $895 at an average share price of $34.92 per share. The aggregate amount of Chemours’ common stock that remained available for purchase under the program at March 31, 2022 was $105.